VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NAKA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NAKANakamoto Inc.
$3.99$69M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

NAKA logoNakamoto Inc.(NAKA)Earnings, Financials & Key Ratios

NAKA•NASDAQ
$3.99
Price updated Jul 7, 2026
SectorHealthcareIndustryMedical EquipmentSub-IndustryDigital Health and Care Delivery
AboutKindly MD, Inc., a healthcare and healthcare data company, provides direct health care services to patients integrating prescription medicine and behavioral health services. The company offers specialty outpatient clinical services based on a subscription and fee-for-service basis to augment traditional healthcare. It provides evaluation and management services, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support, overdose education, peer support, limited urgent care, preventative medicine, travel, and hormone therapy; and data collection and research, and online and email campaign marketing services, as well as engages in the retail sale of health care products through clinics and online. Kindly MD, Inc. was formerly known as Utah Therapeutic Health Center, LLC and changed its name to Kindly MD, Inc. in March 2022. The company was incorporated in 2019 and is based in Salt Lake City, Utah.Show more
  • Revenue$2M-33.0%
  • EBITDA-$197M-6197.8%
  • Net Income-$52M-1343.7%
  • EPS (Diluted)-10.40-1452.2%
  • Gross Margin-508.79%-1542.4%
  • EBITDA Margin-10810.72%-9304.8%
  • Operating Margin-10824.01%-8696.4%
  • Net Margin-2867.65%-2056.0%
  • ROE-20.21%+93.1%

NAKA Price & Volume

Nakamoto Inc. (NAKA) stock price & volume — 10-year historical chart

Loading chart...

Persistent Revenue Contraction Signals Fundamental Business Failure

Investment Thesis • Updated 2026Q1

VerdictNegative
Growth:Contracting
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Unsustainable capital consumption

Key Thesis Takeaways

  • Nakamoto Inc.
  • faces a precarious outlook characterized by a 33.04% year-over-year revenue decline and a structural inability to achieve operational profitability.
  • The company's reliance on goodwill accumulation, which reached $93.5 million in 2026Q1, masks a deteriorating clinical model that has failed to generate sustainable cash flow.
  • Investors should remain cautious as the current liquidity profile, evidenced by a 0.25 current ratio, suggests significant risk to long-term capital preservation.

Verdict Logic

the company's persistent net loss of $238.8 million in 2026Q1 and the lack of a clear path to positive cash flow indicate extreme investment risk.

NAKA Growth Metrics

Nakamoto Inc. (NAKA) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-21.65%
TTM58.64%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-6530.36%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-3947.95%

Return on Capital

10 Years-236.68%
5 Years-236.68%
3 Years-211.36%
Last Year-76.16%

NAKA Recent Earnings

Nakamoto Inc. (NAKA) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 1/12 qtrs (25%)●Beat Revenue 1/12 qtrs (25%)
Q2 2026Latest
May 14, 2026
Metric
Actual
Est
EPS
$15.20-7500.0%
$0.20
Rev
$3M-54.5%
$6M
Q2 2026
Mar 30, 2026
Metric
Actual
Est
EPS
$2.80-366.7%
$0.60
Rev
$444,924+11.2%
$400,000
Q4 2025
Nov 19, 2025
Metric
Actual
Est
EPS
$0.06-500.0%
$0.01
Rev
$388,209-3.0%
$400,200
Q3 2025
Aug 5, 2025
Metric
Actual
Est
EPS
$0.34+97.6%
$14.00
Rev
$400,000-2.1%
$408,500
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestMay 14, 2026
$15.20vs $0.20-7500.0%
$3Mvs $6M-54.5%
Q2 2026Mar 30, 2026
$2.80vs $0.60-366.7%
$444,924vs $400,000+11.2%
Q4 2025Nov 19, 2025
$0.06vs $0.01-500.0%
$388,209vs $400,200-3.0%
Q3 2025Aug 5, 2025
$0.34vs $14.00+97.6%
$400,000vs $408,500-2.1%
Based on last 12 quarters of dataView full earnings history →

Latest NAKA News

Recent stock market news and headlines for Nakamoto Inc. (NAKA)

GlobeNewsWire·Jun 23, 2026
Clear Street Executes First Bitcoin Depositary Receipt Trade Through Prime Brokerage Platform

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Clear Street (“Clear Street” or “the Company”), a cloud-native financial infrastructure technology firm on a mission to give every sophisticated investor access to every asset in every market, today announced the successful execution of Bitcoin Depositary Receipt (“BTC DR”) trades for institutional clients UTXO Management and GTS. Receipts Depositary Corporation (“RDC”) is the Depositary for the Bitcoin DRs and issued the BTC DRs that were subsequently traded; the transactions mark the first time BTC DRs have been traded through a traditional prime brokerage platform and settled through the Depository Trust Company (“DTC”).

Business Wire·Jun 22, 2026
Nakamoto Announces Closing of Legacy Healthcare Clinics

NASHVILLE, Tenn.--(BUSINESS WIRE)--Nakamoto Inc. (Nasdaq: NAKA) (“Nakamoto” or the “Company”) today announced that its healthcare clinics concluded operations on June 19, 2026. Additional administrative activities associated with the wind-down of the Company's legacy healthcare business are expected to be completed in the third quarter of 2026.The clinic closure reflects the Company's full transition to a Bitcoin operating company focused on media & information services, asset management &am.

Peers Comparison

Key metrics vs top competitors for Nakamoto Inc. (NAKA)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
NAKA logoNAKANakamoto Inc.Current
$3.99$69.43M-0.38-33.04%-2867.65%-20.21%—
OPRX logoOPRXOptimizeRx Corporation
$6.29$118.03M23.3018.78%6.37%5.47%—
TALK logoTALKTalkspace, Inc.
$5.20$871.07M130.0022%0.49%1.03%—
DOCS logoDOCSDoximity, Inc.
$22.74$4.25B23.2013.05%30.4%19.36%—
HIMS logoHIMSHims & Hers Health, Inc.
$36.17$7.94B70.9259%-0.56%-2.48%—
WELL logoWELLWelltower Inc.
$237.59$166.46B170.9335.82%12.31%3.49%—

Compare NAKA vs Peers

Nakamoto Inc. (NAKA) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs OPRX

Most directly comparable listed peer for NAKA.

Scale Benchmark

vs UNH

Larger-name benchmark to compare NAKA against a more recognizable public peer.

Peer Set

Compare Top 5

vs OPRX, TALK, DOCS, HIMS

NAKA SEC Filings & Documents

Nakamoto Inc. (NAKA) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

May 22, 2026·SEC

Material company update

May 13, 2026·SEC

Material company update

May 12, 2026·SEC

10-K Annual Reports

2
FY 2026

Mar 30, 2026·SEC

FY 2025

Mar 28, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

May 13, 2026·SEC

FY 2025

Nov 19, 2025·SEC

FY 2025

Aug 5, 2025·SEC

Get notified when NAKA posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

NAKA Frequently Asked Questions

Nakamoto Inc. (NAKA) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Nakamoto Inc.'s revenue?

Nakamoto Inc. (NAKA) reported $3.9M in revenue for fiscal year 2025. This represents a 57% increase from $2.5M in 2021.

How fast is Nakamoto Inc. growing?

Nakamoto Inc. (NAKA) saw revenue decline by 33.0% over the past year.

Is NAKA profitable?

Nakamoto Inc. (NAKA) reported a net loss of $290.0M for fiscal year 2025.

Dividend & Returns
What is NAKA's return on equity?

Nakamoto Inc. (NAKA) has a return on equity (ROE) of -20.2%. Negative ROE indicates the company is unprofitable.

What is Nakamoto Inc.'s free cash flow?

Nakamoto Inc. (NAKA) had negative free cash flow of $46.0M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in NAKA back in 2021?

Total return calculator · dividends reinvested · 5+ years of data

See returns →